1-155066845-A-G

Variant summary

Our verdict is Likely benign.
-2 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -2 classification points (ACMG Germline Pathogenicity v2019). PVS1_ModerateBS2

The NM_001406810.1(EFNA4):c.1A>G (p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. Note: NM_001406810.1 is not a MANE Select or MANE Plus Clinical transcript for EFNA4; the reported annotation may differ from that of the MANE-designated reference transcript for this gene. The variant disrupts the start codon, preventing normal translation initiation. The variant allele was found at a cumulative frequency of 0.0000291 (AC=47) in the gnomAD database across 1,613,898 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00032. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★).

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000018 ( 0 hom. )

Consequence

EFNA4
NM_001406810.1 start_lost

Scores

1
11
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.08

Publications

0 publications found
Variant links:
Genes affected
EFNA4 (HGNC:3224): (ephrin A4) This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNA class ephrin that has been implicated in proliferation and metastasis of several types of cancers. [provided by RefSeq, May 2022]
EFNA4 Gene-Disease associations (from GenCC):
  • craniosynostosis
    Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001406810.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 points.

PVS1
Start-lost with downstream start: >10% CDS truncated — moderate (PVS1 downgraded to PM); Start codon lost (exon 3 of 5); downstream rescue start codon present, but it truncates more than 10% of the CDS.
BS2
Pure AD gene with cumulative gnomAD AC ≥5 — observed in healthy adults (BS2); GnomAD homozygous count = 0.; Cumulative gnomAD AC = 47 (pure AD gene, not AR).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001406810.1. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EFNA4
NM_005227.3
MANE Select
c.229A>Gp.Met77Val
missense
Exon 2 of 4NP_005218.1P52798-1
EFNA4
NM_001406810.1
c.1A>Gp.Met1?
start_lost
Exon 3 of 5NP_001393739.1
EFNA4
NM_182689.2
c.229A>Gp.Met77Val
missense
Exon 2 of 4NP_872631.1P52798-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EFNA4
ENST00000368409.8
TSL:1 MANE Select
c.229A>Gp.Met77Val
missense
Exon 2 of 4ENSP00000357394.3P52798-1
EFNA4
ENST00000359751.8
TSL:1
c.229A>Gp.Met77Val
missense
Exon 2 of 4ENSP00000352789.4P52798-2
EFNA4-EFNA3
ENST00000505139.1
TSL:2
c.113+2909A>G
intron
N/AENSP00000426741.1K9J7H7

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Source / populationAFACHomANCoverage
Global population databases 6 sources
GnomAD3 genomes
0.000138 21015219232
GnomAD2 exomes
0.0000757 19250970
GnomAD4 exome
0.0000178 260146170632
GnomAD4 genome
0.000138 21015219232
TOPMed (Bravo)
0.000117
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
0.000111 4036010
Local & regional cohorts 1 source
ESP6500 (Exome Variant Server)
0.0000769 113006
Showing 7 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
Epi25
(Epilepsy)
0.00 041958 0.0000299 266888
SCHEMA
(Schizophrenia)
0.0000884 10113084 0.0000578 11190474
Showing 2 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)

Computational Scores

AlgorithmCalibrated predictionPredictionScore
AlphaGenome AVI
Pathogenic-22
AlphaMissense
Benign-0.29
BayesDel_addAF
BenignT-0.12
BayesDel_noAF
Uncertain--0.040
CADD
Benign-20
DANN
Uncertain-0.98
DEOGEN2
PathogenicD0.85
Eigen
Benign-0.047
Eigen_PC
Benign-0.13
FATHMM_MKL
UncertainD0.97
FuncVEP CTI
Benign-0.010
GPN-Star LLR
N/A--4.3
GPN-Star score
N/A-4.3
LIST_S2
BenignT0.60
M_CAP
UncertainD0.13
MetaRNN
BenignT0.23
MetaSVM
UncertainD0.34
Mutation Taster
N/Apolymorphism90/10
MutationAssessor
UncertainM2.5
PhyloP100
Uncertain-4.1
popEVE
Benign--3.6
PROVEAN
UncertainD-3.4
RBP_binding_hub_radar
N/A-0.0
RBP_regulation_power_radar
N/A-1.7
REVEL
Uncertain-0.53
Sift
UncertainD0.019
Sift4G
UncertainD0.045
Varity_R
N/A-0.27
VESM-3B
Benign--8.0
Showing 29 of 29 scores

Splicing Scores

AlgorithmCalibrated predictionPredictionScore
Pangolin (max)
Benign-0.040
SpliceAI score (max)
Benign-
Details are displayed if max score is > 0.2
0.080
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.